ArticleProceedings of the National Academy of Sciences of the United States of America2013

Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.

David Sánchez-Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.